Document center

Five information notes for Marie Skłodowska-Curie actions fellows and staff members (2023 and 2024)

Published on | 1 year ago

Programmes MSCA

Five information notes for Marie Skłodowska-Curie actions (MSCA) fellows and staff members

  • Information package for Marie Skłodowska-Curie fellows (June 2024) (link)
  • Information note for Marie Skłodowska-Curie fellows in a co-funding of regional, national and international programme (COFUND) (June 2024) (link) This document complements the general Information package for Marie Skłodowska-Curie fellows with information on the conditions of appointment and remuneration specifically for those holding an MSCA fellowship as part of a Co-funding of regional, national and international programmes (COFUND). Quotations in italics are from the Horizon Europe Unit Model Grant Agreement (HE MGA) for COFUND.
  • Information note for Marie Skłodowska-Curie staff members in staff exchanges (June 2024) (link) This document provides information on the conditions for, and the financing of, secondments as part of a Staff Exchanges (SE) projects and complements the general Information package for Marie Skłodowska-Curie fellows.
  • Information note for Marie Skłodowska-Curie fellows in doctoral networks (June 2024) (link) This document complements the general Information package for Marie Skłodowska-Curie fellows with information on the conditions of appointment and remuneration specifically for those holding an MSCA fellowship as part of a Doctoral Network (DN) project. Quotations in italics are from the Horizon Europe Model Grant Agreement (HE MGA) on unit grants with information on the conditions of appointment and remuneration specifically for those holding an MSCA fellowship as part of a Doctoral Network (DN) project.
  • Information note for Marie Skłodowska-Curie Fellows in postdoctoral fellowships (December 2023) (link) The purpose of this short guide is to provide some information and anticipate some questions relating to the implementation of the Fellowship under Horizon Europe, the EU’s key funding programme for research and innovation.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.